Sunday 18 October 2026
Export QTTB’s income statement to Excel — free account
Q32 Bio Inc.
QTTB Healthcare Biotechnology
Q32 Bio Inc.’s revenue for fiscal 2025 (year ended December 2025) was $53.7 million. In the quarter to June 2026, EPS grew 43.6%, free cash flow grew 71.1% and total debt fell 35.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.52
0.25
−3.22%
Follow QTTB
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
1.43 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Piotroski F-Score |
— | — | — | 1 | 3 | 2 | — | — | — | — |
Altman Z-Score |
(0.78) | — | (8.70) | (2.85) | (0.28) | 2.13 | 8.98 | 5.77 | — | — |
P/S ratio |
0.00 | — | 0.00 | 21.49 | 5.93 | 191.98 | 523.74 | 120.06 | — | — |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(2.11) | — | (18.45) | (1.79) | 0.07 | 0.56 | 6.11 | 5.57 | — | — |
P/Operating CF |
(6.61) | — | (0.35) | (2.53) | (6.62) | (44.67) | (33.14) | (79.09) | — | — |
P/B ratio |
0.97 | — | 0.00 | 0.39 | 1.19 | 2.65 | 3.38 | 3.25 | — | — |
Price to Tangible BV |
0.97 | — | 0.00 | 0.39 | 1.19 | 2.65 | 3.38 | 3.25 | — | — |
EV/Sales |
(0.34) | — | (3.34) | (23.88) | 2.04 | 117.23 | 366.25 | 79.71 | — | — |
EV/EBITDA |
0.00 | — | 0.00 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(0.07) | — | (1.19) | 0.67 | (0.63) | (3.36) | (6.68) | (9.97) | — | — |
EV/FCF |
(0.08) | — | (1.19) | 0.67 | (0.62) | (3.23) | (5.39) | (6.28) | — | — |
Quick Ratio |
4.26 | 4.74 | 1.82 | 7.75 | 9.05 | 9.60 | 21.20 | 9.54 | 14.63 | 1.79 |
Current Ratio |
4.85 | 4.97 | 2.04 | 8.02 | 11.14 | 9.69 | 21.54 | 9.84 | 14.85 | 1.88 |
Net Debt/EBITDA |
(2.21) | 1.00 | (0.39) | 1.09 | 1.52 | 1.65 | 2.53 | 3.66 | 4.48 | 1.17 |
Debt/Assets |
15.71% | 13.70% | 93.62% | 12.90% | 11.30% | 5.86% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.23 | 2.23 | (0.62) | 0.17 | 0.14 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.70 | 0.00 | (0.05) | 0.01 | 0.14 | 0.01 | 0.01 | 0.03 | 0.00 | 0.00 |
Operating CF/Net income |
(1.12) | 1.42 | 0.35 | 22.71 | 1.15 | 0.73 | 0.88 | 0.77 | (0.22) | 1.05 |
Capex/Depreciation |
12.26 | (0.16) | (0.01) | 1.96 | (0.26) | (0.48) | (3.46) | (19.35) | (2.86) | (8.30) |
| 125.06% | 53.86% | 2,174.51% | (2.88%) | (52.38%) | (56.63%) | (45.69%) | (70.84%) | 121.55% | 32.61% | |
| 38.70% | (68.49%) | (39.01%) | (2.27%) | (40.28%) | (44.82%) | (36.48%) | (28.03%) | (39.53%) | (10.61%) | |
ROIC |
308.43% | 0.00% | 0.00% | (256.87%) | (159.02%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
66.74% | (71.48%) | (327.92%) | (3.14%) | (54.12%) | (55.02%) | (35.00%) | (23.67%) | (23.82%) | (106.37%) |
Average Days of Receivables |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Research and Development Expense of Revenue |
35.65% | 0.00% | (477.06%) | 3,065.80% | 274.01% | 3,715.47% | 5,366.03% | 900.94% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
32.90% | 0.00% | (148.47%) | 1,188.84% | 108.43% | 1,205.51% | 1,333.19% | 325.07% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
9.78% | 0.00% | (21.47%) | 406.92% | 50.76% | 490.30% | 458.28% | 49.29% | 0.00% | 0.00% |
Graham Net Nets |
0.86 | — | (23.71) | 1.89 | 0.74 | 0.29 | 0.25 | 0.25 | — | — |
Graham Number |
13.35 | — | 1,347.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
69.88% | — | (1,419.03%) | (7.49%) | (46.39%) | (24.78%) | (11.92%) | (24.44%) | — | — |
Free Cash Flow Yield |
(65.18%) | — | (493.22%) | (166.75%) | (55.68%) | (18.90%) | (12.97%) | (10.56%) | — | — |
Revenue per Share |
4.37 | 0.00 | (19.05) | 1.01 | 11.05 | 1.06 | 0.71 | 3.35 | 0.00 | 0.00 |
Operating CF per Share |
(2.73) | (7.26) | (53.50) | (35.61) | (35.71) | (36.96) | (39.01) | (26.81) | 47.02 | (80.27) |
Capex per Share |
0.57 | (0.01) | (0.01) | (0.40) | (0.78) | (1.46) | (9.32) | (15.71) | (14.21) | (18.82) |
Free Cash Flow per Share |
(2.16) | (7.27) | (53.51) | (36.02) | (36.48) | (38.42) | (48.33) | (42.52) | 32.81 | (99.09) |
Cash per Share |
3.93 | 8.36 | 73.38 | 54.84 | 50.71 | 85.18 | 112.05 | 135.27 | 940.92 | 107.78 |
Shareholders Equity per Share |
3.42 | 0.61 | (204.74) | 55.77 | 55.19 | 76.78 | 110.39 | 123.69 | 713.41 | 70.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.42 | 0.61 | (204.74) | 55.77 | 55.19 | 76.78 | 110.39 | 123.69 | 713.41 | 70.96 |
Free Cash Flow |
(26.54) | (67.79) | (18.68) | (114.95) | (112.15) | (98.06) | (113.19) | (67.50) | 4.52 | (10.47) |
Working Capital |
43.70 | 65.41 | 14.61 | 158.44 | 174.68 | 196.91 | 254.20 | 199.17 | 122.74 | 5.61 |
Capital Expenditures |
7.00 | (0.07) | 0.00 | (1.28) | (2.40) | (3.73) | (21.83) | (24.94) | (1.96) | (1.99) |
Net Current Asset Value |
35.29 | (4.78) | (89.82) | 130.52 | 149.84 | 151.82 | 214.52 | 158.95 | 92.38 | 5.27 |
EV/EBIT |
0.13 | — | 0.00 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
(0.13) | 0.00 | 0.00 | 0.40 | 0.07 | 1.38 | 13.11 | 4.69 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.58 | 0.34 | 0.33 | (0.61) | 4.11 | 0.21 | 0.15 | 0.04 | 0.22 | 0.12 |
Cash ROIC |
(26.54%) | (70.40%) | 1,035.01% | (30.05%) | (32.09%) | (22.87%) | (21.73%) | (16.42%) | 1.98% | (55.44%) |
Accounts Receivable Turnover |
0.00 | — | 0.00 | 0.00 | 0.00 | 6.76 | 2.78 | 11.65 | — | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | 0.40 | 0.60 | 0.46 | — | 0.46 |
Average Payables |
1.93 | 3.23 | 2.31 | 1.76 | 3.54 | 3.67 | 9.17 | 9.14 | 1.72 | 1.72 |
Average Assets |
77.05 | 69.69 | 137.76 | 220.10 | 237.73 | 287.15 | 284.83 | 198.31 | 75.87 | 75.87 |
Average Common Equity |
23.84 | (88.62) | (2.47) | 173.81 | 182.82 | 227.25 | 227.43 | 78.45 | (24.67) | (24.67) |
Columns are period end dates